Hospital-based use of thromboprophylaxis in patients with COVID-19.

Spyropoulos, Alex C; Ageno, Walter; Barnathan, Elliot S

Spyropoulos, Alex C; Ageno, Walter; Barnathan, Elliot S.

Spyropoulos AC; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Center for Health Innovation and Outcomes Research, Feinstein Institutes for Medical Research, Department of Medicine, Northwell Health at Lenox Hill Hospital, New York City, 10577 NY, USA. Electronic address: aspyropoul@northwell.edu.
Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Barnathan ES; Janssen Research and Development, Spring House, PA, USA.

Lancet ; 395(10234): e75, 2020 05 02.

Article in English | MEDLINE | ID: covidwho-97147

Subject(s)

Coronavirus; Venous Thromboembolism; Anticoagulants; Betacoronavirus; COVID-19; Coronavirus Infections; Humans; Pandemics; Pneumonia, Viral; Prognosis; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Venous Thromboembolism Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google